Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...
How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...
The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs -- bebtelovimab, sotrovimab, casirivimab ...
Hosted on MSN
How COVID-19 variants outsmart the immune system
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use authorization to market a ...
Though the peak of COVID-19 deaths is thankfully behind us, the virus is still a pernicious public health threat that vexes drugmakers by constantly evolving new variants that can elude existing ...
An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...
A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results